北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus
作者: Guo, Xiao-hui1; Lv, Xiao-feng2; Han, Ping3; Zhang, Xiu-zhen4; Yang, Hua-zhang5; Duan, Wen-ruo6; Gao, Yan1
关键词: Glimepiride ; Initial treatment ; Type 2 diabetes mellitus
刊名: CURRENT MEDICAL RESEARCH AND OPINION
发表日期: 2013-03-01
DOI: 10.1185/03007995.2013.765396
卷: 29, 期:3, 页:169-174
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal ; Medicine, Research & Experimental
研究领域[WOS]: General & Internal Medicine ; Research & Experimental Medicine
关键词[WOS]: PREVALENCE ; SULFONYLUREA ; AGENTS ; NIDDM
英文摘要:

Objective:

To investigate the efficacy and safety of glimepiride as initial mono-therapy in type 2 diabetes patients in China.

Methods:

This is a multi-center, open-label, single arm study. A total of 391 subjects were enrolled to receive glimepiride treatment for 16 weeks, the initiation dose was 1 mg/d, with titration to 2 mg/d and 4 mg/d according to the fasting blood glucose (FBG) level measured at each visit. The change in HbA1c, fasting plasma glucose (FPG), 2 h postprandial blood glucose (2hPPG), HOMA-IR, weight, waist circumference and the incidence of hypoglycemia were evaluated. An exploratory analysis was conducted to identify the potential population prone to achieve target glycemic control.

Results:

HbA1c was reduced significantly from 8.6 +/- 1.6% to 6.9 +/- 0.9% (p<0.001); 60.9% of the subjects achieved HbA1c <7% at study endpoint. The reduction in FPG and 2hPPG were 2.3 mmol/L and 4.4 mmol/L (p<0.001) respectively. Insulin resistance was improved significantly with HOMA-IR decreasing from 2.5 +/- 2.3 to 2.2 +/- 1.9 (p=0.009). The incidence of confirmed hypoglycemia (BG <= 3.9 mmol/L) was 3.1%.

Conclusions:

Glimepiride treatment as initial mono-therapy could effectively improve blood glucose control in type 2 diabetic patients, with a favorable safety profile. Lack of control group was the major limitation of this study.

语种: 英语
项目资助者: Sanofi (China) Investment Co. Ltd. ; Sanofi
WOS记录号: WOS:000314851000002
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/62733
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 1, Beijing 100034, Peoples R China
2.Beijing PLA, Mil Gen Hosp, Beijing, Peoples R China
3.China Med Univ, Shengjing Hosp, Shenyang, Peoples R China
4.Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
5.Qingdao Municipal Hosp, Qingdao, Peoples R China
6.Tongji Univ, Tongji Hosp, Sch Med, Shanghai 200092, Peoples R China

Recommended Citation:
Guo, Xiao-hui,Lv, Xiao-feng,Han, Ping,et al. Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus[J]. CURRENT MEDICAL RESEARCH AND OPINION,2013,29(3):169-174.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Guo, Xiao-hui]'s Articles
[Lv, Xiao-feng]'s Articles
[Han, Ping]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Guo, Xiao-hui]‘s Articles
[Lv, Xiao-feng]‘s Articles
[Han, Ping]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace